Low-dose atropine therapy is a prescription eye drop option that may be used as part of a myopia management plan for certain children. Myopia, also known as nearsightedness, can progress as children grow, and slowing that progression may help reduce the risk of higher myopia later in life.
At InnoVision Optometry, low-dose atropine is one of several treatment options Dr. Su may discuss during a myopia management consultation. Because every child is different, we will review your child’s age, prescription, eye health, risk factors, and treatment goals before determining whether atropine is appropriate.
Low-dose atropine is not FDA-approved for myopia control in the United States. When used for myopia management, it is prescribed off-label.
Off-label prescribing means a medication is being used in a way that is not specifically approved by the FDA for that condition. This is common in many areas of healthcare when a doctor determines that a treatment may be appropriate based on clinical judgment, available research, and the patient’s individual needs.
Dr. Su will review this with you before recommending low-dose atropine therapy so your family can make an informed decision.
Atropine is an eye drop medication that has been used in eye care for many years. In myopia management, a much lower concentration may be prescribed to help slow the progression of nearsightedness in certain children.
Unlike glasses or contact lenses, atropine does not directly correct blurry distance vision. Your child will still need glasses or contact lenses to see clearly. The purpose of low-dose atropine therapy is to help slow how quickly the prescription changes over time.

Low-dose atropine may be considered for children who:
Because atropine is a prescription medication, Dr. Su will carefully review your child’s eye health, symptoms, medical history, and risk factors before recommending treatment.
If low-dose atropine is recommended, Dr. Su will explain how the drops are used, how often they should be taken, and what follow-up schedule is needed. Consistency is important, and parents play an important role in helping children use the drops as directed.
During follow-up visits, Dr. Su will monitor your child’s prescription, eye health, symptoms, and myopia progression. The treatment plan may be adjusted over time depending on how your child responds.
Low-dose atropine is generally intended to reduce the chance of side effects compared with stronger concentrations, but side effects are still possible. Some children may experience light sensitivity, larger pupils, mild eye irritation, or difficulty focusing up close.
If your child experiences significant discomfort, redness, allergy symptoms, blurred vision, light sensitivity, or any concerning reaction, contact our office promptly.
Low-dose atropine is one of several myopia management options available at InnoVision Optometry. Depending on your child’s needs, Dr. Su may also discuss Essilor® Stellest® lenses, CooperVision® MiSight® 1 day contact lenses, or Ortho-K.
There is no single best treatment for every child. Some families prefer glasses-based treatment, some children do well with contact lenses, and others may be better suited for medication-based therapy. Our goal is to help your family understand the benefits, limitations, and responsibilities of each option.
If your child’s glasses prescription keeps getting stronger, low-dose atropine may be one option to consider as part of a personalized myopia management plan. Schedule a complimentary myopia consultation at InnoVision Optometry in Rowland Heights to learn which treatment options may be appropriate for your child.